Hice esta plataforma con información verificada de los insumos que necesitan en tiempo real los hospitales, refugios, ONGs y demás centros que atienden la emergencia.
Solo pueden publicar ellos.
Si tienes un centro de acopio o quieres donar, entra para ver dónde se necesita.
Si eres un médico en un centro de salud y quieres unirte, escríbeme acá para sumarte.
Hagamos que la ayuda llegue a donde realmente se necesita.
https://t.co/ly8XikSBns 🤝
He creado https://t.co/DrUkKVVJTN para recopilar únicamente personas que aparecen en las listas de hospitales.
El código es abierto y la API publica para que todas las plataformas y organismos crucen datos sin problemas.
Comparte y si eres programador ayudame en github.
🚨 Plataforma para reportar y encontrar personas desaparecidas tras el terremoto.
Reporta aquí en 1 minuto 👇
https://t.co/1FsbxKMciq
Comparte. Ayuda a reconectar familias ❤️
#venezuela#noticias#desaparecidos#terremoto
Muchos misterios son explicables, excepto el misterio de por qué cuesta dormirse en las noches, mientras que dormir en la mañana se siente como si estuvieras en una nube esponjosa de algodon egipcio con Adele cantandote una canción de cuna.
Revolución desde Chile: una científica crea el primer probiótico capaz de eliminar la bacteria que causa la gastritis, una enfermedad común en la población. Sin antibióticos ni efectos secundarios… y podría cambiarlo todo. 👇
The first lung cancer vaccine, BNT116, developed by @BioNTech_Group, will be tested in a phase 1 clinical trial across seven countries, including Spain. This mRNA-based vaccine aims to train the immune system to fight non-small cell lung carcinoma. In Spain, hospitals in five cities will participate, involving 130 patients in various stages of the disease. The goal is to enhance the immune response against cancer while sparing healthy cells. 👏👏
#Science #GoodNews
https://t.co/NMwhCFwSJe
🤖 BrainBridge, the first head transplant system, uses robotics and AI for head and face transplants, offering hope to those with severe conditions like stage-4 cancer and neurodegenerative diseases…
Redefining the boundaries of human capability requires pioneers.
If you have quadriplegia and want to explore new ways of controlling your computer, we invite you to participate in our clinical trial.
🚨12,500 left til Round is completed for $Kelp!🚨
🦑 Last call til round is full kelpers!
🧐 Have you reserved your spot in #Kelp
⬇️ Download the app and find out why everyone is switching over to Kelp!
https://t.co/H2XbswqvlP
https://t.co/0JFnz0QsQu
Heyo Conda Fam!
Hosting my first AMA with @kelporg in my TG Please join to learn about what they got cookin up and a chance to win some $$$$$
YEEEEE!
https://t.co/8zCUxqyDbo
TECH: ChatGPT4 has 'outperformed' internal medicine residents and attending physicians in' processing medical data and demonstrating clinical reasoning', according to a research letter published in JAMA Internal Medicine.
100% Cancer Remission Achieved in ALL Patients of Groundbreaking Study
Dr. Andrea Cercek, one of the lead researchers, said:
“It’s absolutely incredible ... We’ve certainly never seen this before.”
All 12 patients experienced complete rectal cancer remission after receiving dostarlimab, a monoclonal antibody.
This particular monoclonal antibody achieved 100% cancer remission without chemotherapy, radiation, surgery, or the toxic side effects that come with such therapies.
The authors wrote:
“All 12 patients (100%; 95% confidence interval) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging ... and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months after treatment). No adverse events of grade 3 or higher have been reported.”
How does this monoclonal antibody actually work?
Dr. Andrea Cercek explained that it essentially unlocks the body’s ability to heal itself.